Head of Solution Design and Delivery - IT at Roivant Sciences

New York, New York, United States

Roivant Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Healthcare TechnologyIndustries

Requirements

  • Highly skilled and visionary leader with deep technical expertise
  • Strategic thinker with a passion for innovation
  • Ability to lead high-performing teams in a complex, fast-paced, and regulated environment
  • Expertise in requirements gathering, enterprise/technical architecture, application and solution design, development, delivery, and post go-live support
  • Experience forecasting technical supply/demand, architecting solutions, designing, developing, testing, and delivering new solutions
  • Technical leadership in SaaS infrastructure, endpoint management, design-thinking, and support practices
  • Ability to translate business requirements and functional specifications into application designs and software solutions
  • Hands-on involvement in multiple projects across the portfolio

Responsibilities

  • Lead, mentor, and manage the Solution Design and Delivery (SD&D) team, fostering a high-performance culture that values collaboration, continuous learning, and innovation
  • Build, develop, and retain a high-performing team, providing coaching and guidance for skills, tools, and growth opportunities
  • Execute on and direct team members through all system development lifecycle phases, ensuring adherence to methodologies, policies, standards, and controls
  • Provide technical leadership and execution in SaaS infrastructure, endpoint management, design-thinking, and support practices
  • Develop and execute a comprehensive strategy that supports the company’s overall goals
  • Build and review design, development, and support strategy and plan for strategic programs
  • Drive continuous improvement of IT operations by implementing automations, streamlining workflows, and reducing manual intervention
  • Discover and understand company and team needs to evaluate and source tools and other solutions as needed

Skills

Solution Design
Requirements Gathering
Enterprise Architecture
Technical Architecture
Application Development
Team Leadership
IT Strategy

Roivant Sciences

Develops biopharmaceuticals and RNA therapeutics

About Roivant Sciences

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates in the biopharmaceutical market, which involves creating drugs from biological sources. Roivant's unique business model combines in-house development with strategic partnerships, allowing it to build a strong pipeline of drug candidates and utilize advanced technologies to meet medical needs. A key subsidiary, Genevant, specializes in RNA therapeutics, employing proprietary delivery platforms for mRNA, RNAi, and gene editing to treat specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

New York City, New YorkHeadquarters
2014Year Founded
$1,750.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options

Risks

Integration challenges from Dermavant acquisition may disrupt operations and delay development.
Regulatory hurdles in Pulmovant collaboration with Bayer could impede progress.
Failure of lupus drug brepocitinib may lead to financial losses and investor concerns.

Differentiation

Roivant Sciences focuses on late-stage drug candidates, reducing development time and cost.
The company builds Vants, nimble biotech firms, to enhance drug development efficiency.
Roivant leverages RNA therapeutics, including mRNA and RNAi, for innovative treatments.

Upsides

Roivant's acquisition of Dermavant expands its dermatology portfolio and therapeutic areas.
Strategic partnerships with Bayer and Roche accelerate drug development and market entry.
Increased investment from financial institutions highlights confidence in Roivant's growth potential.

Land your dream remote job 3x faster with AI